vs

Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and Invesco (IVZ). Click either name above to swap in a different company.

Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.6B vs $1.7B, roughly 1.6× Invesco). Delek US Holdings, Inc. runs the higher net margin — -7.7% vs -58.9%, a 51.2% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs -4.9%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -10.8%).

Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

DK vs IVZ — Head-to-Head

Bigger by revenue
DK
DK
1.6× larger
DK
$2.6B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+11.1% gap
IVZ
6.2%
-4.9%
DK
Higher net margin
DK
DK
51.2% more per $
DK
-7.7%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-10.8%
DK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DK
DK
IVZ
IVZ
Revenue
$2.6B
$1.7B
Net Profit
$-201.3M
$-995.9M
Gross Margin
-5.8%
Operating Margin
-86.2%
Net Margin
-7.7%
-58.9%
Revenue YoY
-4.9%
6.2%
Net Profit YoY
-575.8%
EPS (diluted)
$-3.34
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DK
DK
IVZ
IVZ
Q1 26
$2.6B
Q4 25
$2.4B
$1.7B
Q3 25
$2.9B
$1.6B
Q2 25
$2.8B
$1.5B
Q1 25
$2.6B
$1.5B
Q4 24
$2.4B
$1.6B
Q3 24
$3.0B
$1.5B
Q2 24
$3.3B
$1.5B
Net Profit
DK
DK
IVZ
IVZ
Q1 26
$-201.3M
Q4 25
$78.3M
$-995.9M
Q3 25
$178.0M
$356.4M
Q2 25
$-106.4M
$197.4M
Q1 25
$-172.7M
$171.1M
Q4 24
$-413.8M
$209.3M
Q3 24
$-76.8M
$55.0M
Q2 24
$-37.2M
$132.2M
Gross Margin
DK
DK
IVZ
IVZ
Q1 26
-5.8%
Q4 25
9.3%
Q3 25
13.8%
Q2 25
1.9%
Q1 25
-2.4%
Q4 24
-5.7%
Q3 24
-0.7%
Q2 24
0.5%
Operating Margin
DK
DK
IVZ
IVZ
Q1 26
Q4 25
6.8%
-86.2%
Q3 25
10.2%
16.5%
Q2 25
-1.2%
14.1%
Q1 25
-4.8%
18.1%
Q4 24
-17.0%
19.6%
Q3 24
-4.0%
6.6%
Q2 24
0.1%
13.9%
Net Margin
DK
DK
IVZ
IVZ
Q1 26
-7.7%
Q4 25
3.2%
-58.9%
Q3 25
6.2%
21.7%
Q2 25
-3.8%
13.0%
Q1 25
-6.5%
11.2%
Q4 24
-17.4%
13.1%
Q3 24
-2.5%
3.6%
Q2 24
-1.1%
8.9%
EPS (diluted)
DK
DK
IVZ
IVZ
Q1 26
$-3.34
Q4 25
$1.23
$-2.61
Q3 25
$2.93
$0.66
Q2 25
$-1.76
$-0.03
Q1 25
$-2.78
$0.38
Q4 24
$-6.48
$0.46
Q3 24
$-1.20
$0.12
Q2 24
$-0.58
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DK
DK
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$624.1M
$1.0B
Total DebtLower is stronger
$3.2B
$1.8B
Stockholders' EquityBook value
$302.0M
$12.2B
Total Assets
$7.6B
$27.1B
Debt / EquityLower = less leverage
10.54×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DK
DK
IVZ
IVZ
Q1 26
$624.1M
Q4 25
$625.8M
$1.0B
Q3 25
$630.9M
$973.1M
Q2 25
$615.5M
$922.7M
Q1 25
$623.8M
$821.7M
Q4 24
$735.6M
$986.5M
Q3 24
$1.0B
$1.0B
Q2 24
$657.9M
$878.5M
Total Debt
DK
DK
IVZ
IVZ
Q1 26
$3.2B
Q4 25
$3.2B
$1.8B
Q3 25
$3.2B
$1.6B
Q2 25
$3.1B
$1.9B
Q1 25
$3.0B
$964.8M
Q4 24
$2.8B
$890.6M
Q3 24
$2.8B
$890.3M
Q2 24
$2.5B
$890.1M
Stockholders' Equity
DK
DK
IVZ
IVZ
Q1 26
$302.0M
Q4 25
$547.3M
$12.2B
Q3 25
$444.8M
$14.0B
Q2 25
$294.9M
$13.9B
Q1 25
$429.4M
$14.7B
Q4 24
$575.2M
$14.6B
Q3 24
$875.4M
$14.8B
Q2 24
$982.8M
$14.6B
Total Assets
DK
DK
IVZ
IVZ
Q1 26
$7.6B
Q4 25
$6.8B
$27.1B
Q3 25
$7.1B
$28.4B
Q2 25
$7.1B
$28.5B
Q1 25
$6.9B
$28.1B
Q4 24
$6.7B
$27.0B
Q3 24
$7.0B
$27.5B
Q2 24
$6.9B
$27.2B
Debt / Equity
DK
DK
IVZ
IVZ
Q1 26
10.54×
Q4 25
5.91×
0.15×
Q3 25
7.14×
0.12×
Q2 25
10.51×
0.14×
Q1 25
7.07×
0.07×
Q4 24
4.81×
0.06×
Q3 24
3.19×
0.06×
Q2 24
2.50×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DK
DK
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DK
DK
IVZ
IVZ
Q1 26
Q4 25
$502.8M
$455.8M
Q3 25
$44.0M
$606.2M
Q2 25
$51.4M
$547.9M
Q1 25
$-62.4M
$-84.6M
Q4 24
$-163.5M
$316.9M
Q3 24
$-21.6M
$438.4M
Q2 24
$-48.4M
$489.1M
Free Cash Flow
DK
DK
IVZ
IVZ
Q1 26
Q4 25
$382.8M
$432.2M
Q3 25
$-64.0M
$586.4M
Q2 25
$-114.4M
$530.4M
Q1 25
$-198.1M
$-108.0M
Q4 24
$-354.0M
$309.9M
Q3 24
$-140.6M
$410.0M
Q2 24
$-128.3M
$462.4M
FCF Margin
DK
DK
IVZ
IVZ
Q1 26
Q4 25
15.8%
25.5%
Q3 25
-2.2%
35.7%
Q2 25
-4.1%
35.0%
Q1 25
-7.5%
-7.1%
Q4 24
-14.9%
19.5%
Q3 24
-4.6%
27.1%
Q2 24
-3.9%
31.2%
Capex Intensity
DK
DK
IVZ
IVZ
Q1 26
Q4 25
4.9%
1.4%
Q3 25
3.7%
1.2%
Q2 25
6.0%
1.2%
Q1 25
5.1%
1.5%
Q4 24
8.0%
0.4%
Q3 24
3.9%
1.9%
Q2 24
2.4%
1.8%
Cash Conversion
DK
DK
IVZ
IVZ
Q1 26
Q4 25
6.42×
Q3 25
0.25×
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
Q2 24
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DK
DK

Segment breakdown not available.

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons